entertainment -WSS

entertainment

author：entertainment 2025-08-23 08:56:57 - browse：29

A dosage of Wegovy, a drug used for weight loss — Amanda Andrade-Rhoades/AP

U.S. regulators approved a label expansion for Novo Nordisk’s obesity drug Wegovy to tout its benefits for the heart, a move that could boost demand and insurance coverage for the already highly popular treatment.

The new label indicates that Wegovy can be used to reduce the risk of major heart complications — including heart attack, stroke, or cardiovascular-related deaths — for people with overweight or obesity and existing heart disease, Novo said in a statement Friday.

The decision was based on results of a large, five-year trial that showed Wegovy cut the risk of cardiovascular problems by 20% in that population. This is the first time a weight loss treatment has been approved to also help improve heart outcomes, the FDA said.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： Global childhood vaccinations edge closer to pre

WSS

Mike Pence clashes with Tucker Carlson in Iowa

Grail faces three suits alleging harassment, retaliation

Congress: Eradicate hepatitis C and reduce the deficit

Involuntary treatment for addiction doesn't work

Everything to know for the next Powerball drawing as jackpot hits $1 billion

CMS got Medicare Advantage quality rating wrong, judge rules

Wikipedia

entertainment

focus

Peter Hotez and the public health issue of online harassment

Medicare eyes cuts to doctors, raises to outpatient clinics in 2024

ChatGPT in medicine: STAT answers readers' burning questions

STAT wants to know your pick for a great summer read or listen

Affirmative action in medical school literally saved lives

Celiac disease study examines precisely how gluten triggers injury

The cancer drug shortage isn’t new — and neither are the solutions

Senators tussle over abortion against the backdrop of a presidential campaign

BioMarin wins approval for gene therapy to treat hemophilia A

Why police arrested suspected Gilgo Beach killer away from his house

leisure time

Congress needs to close a vaccine

Care demand spikes challenge UnitedHealth’s provider arm

ASCO Daily Recap: CAR

STAT wants to know your pick for a great summer read or listen

Georgia court denies Trump's request to quash DA's 2020 election probe

For pregnant people, addiction treatment shouldn't mean a call to child protective services

entertainment

hotspot

focus

hotspot